Molecular link mechanisms between inflammation and cancer

DB Vendramini-Costa… - Current pharmaceutical …, 2012 - ingentaconnect.com
Inflammation is part of the body's response to internal and external environmental stimuli
that normally eliminate the aggressor agent and restore the tissue physiology. However …

Nitric oxide-donating non-steroidal anti-inflammatory drugs: the case of nitroderivatives of aspirin

V Chiroli, F Benedini, E Ongini, P Del Soldato - European journal of …, 2003 - Elsevier
Nitric oxide (NO) acts as a key signalling mechanism in a number of cells and tissues in the
mammalian organism. Modulation of the biosynthesis of NO has emerged to be relevant to …

Nitric Oxide—Releasing NSAIDs: A Review of Their Current Status

S Fiorucci, E Antonelli, JL Burgaud, A Morelli - Drug safety, 2001 - Springer
Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most widely prescribed drugs
worldwide owing to their anti-inflammatory, antipyretic and analgesic properties. However …

In vitro metabolism of nitric oxide-donating aspirin: the effect of positional isomerism

J Gao, K Kashfi, B Rigas - Journal of Pharmacology and Experimental …, 2005 - ASPET
NO-donating aspirin (NO-ASA) is a potentially important chemopreventive agent against
cancer. Since positional isomerism affects strongly its potency in inhibiting colon cancer cell …

Chemopreventive efficacy of naproxen and nitric oxide–naproxen in rodent models of colon, urinary bladder, and mammary cancers

VE Steele, CV Rao, Y Zhang, J Patlolla, D Boring… - Cancer Prevention …, 2009 - AACR
Nonsteroidal anti-inflammatory drugs (NSAID) have been highly effective in preventing
colon, urinary bladder, and skin cancer preclinically, and also in clinical trials of colon …

Targeting inflammation in cancer prevention and therapy

J Todoric, L Antonucci, M Karin - Cancer Prevention Research, 2016 - AACR
Inflammation is associated with the development and malignant progression of most
cancers. As most of the cell types involved in cancer-associated inflammation are genetically …

A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro

P Andrews, X Zhao, J Allen, F Li, M Chang - Cancer chemotherapy and …, 2008 - Springer
Purpose Previously, we reported in vitro observations suggesting that ibuprofen is an
effective non-prescription non-steroidal anti-inflammatory drug (NSAID) to reduce the …

A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity

GA Piazza, AB Keeton, HN Tinsley, BD Gary… - Cancer Prevention …, 2009 - AACR
Nonsteroidal anti-inflammatory drugs such as sulindac have shown promising antineoplastic
activity, although toxicity from cyclooxygenase (COX) inhibition and the suppression of …

[HTML][HTML] Non-steroidal anti-inflammatory drugs in prevention of gastric cancer

Y Dai, WH Wang - World journal of gastroenterology: WJG, 2006 - ncbi.nlm.nih.gov
Non-steroidal anti-inflammatory drugs (NSAIDs) including cyclooxygenase 2 (COX-2)
selective inhibitors, are potential agents for the chemoprevention of gastric cancer …

Colon tumor cell growth–inhibitory activity of sulindac sulfide and other nonsteroidal anti-inflammatory drugs is associated with phosphodiesterase 5 inhibition

HN Tinsley, BD Gary, J Thaiparambil, N Li, W Lu… - Cancer Prevention …, 2010 - AACR
Nonsteroidal anti-inflammatory drugs (NSAID) display promising antineoplastic activity, but
toxicity resulting from cyclooxygenase (COX) inhibition limits their clinical use for …